Gaxos.ai Inc. (NASDAQ: GXAI), a developer of artificial intelligence applications for high-growth sectors, has closed the exercise of outstanding warrants, generating approximately $3.6 million in gross proceeds. The transaction, announced recently, involved the purchase of up to 3,007,654 shares of common stock at a reduced exercise price of $1.20 per share. H.C. Wainwright & Co. served as the exclusive placement agent.
In consideration for the cash exercise, Gaxos issued new unregistered warrants to purchase up to 6,015,308 shares at an exercise price of $0.95 per share. The company intends to use the net proceeds for working capital and general corporate purposes, providing a financial boost to its ongoing AI initiatives.
This capital infusion comes at a pivotal time as Gaxos.ai expands its portfolio of AI-powered solutions across defense, health and wellness, entertainment, and productivity. The company aims to make advanced technology more practical, accessible, and transformative, with a focus on delivering meaningful real-world outcomes. The warrant exercise not only strengthens Gaxos's balance sheet but also signals investor confidence in its strategic direction.
Investors and industry observers will be watching how Gaxos deploys these funds to advance its AI projects and compete in an increasingly crowded market. The company's ability to secure additional capital through warrant exercises reflects a proactive approach to funding its growth without diluting existing shareholders excessively.
For more details on the transaction, the full press release is available at https://ibn.fm/XKeDG. The latest news and updates on GXAI can be found in the company's newsroom at https://ibn.fm/GXAI.
The AI sector continues to attract significant investment, and Gaxos.ai's successful warrant exercise underscores its commitment to capitalizing on emerging opportunities. As the company moves forward, its ability to execute on its AI roadmap will be key to delivering value to shareholders and stakeholders alike.
